ResMed Inc. (RMD): An Asymmetric Risk Analysis of the Sleep-Disordered Breathing Monopoly

from The Gemini Brief - Investment Deep Dives · host Lukasz Tomicki and LRT Capital Management LLC

Slide Deck 1. Executive Summary: The Quality Trap ResMed Inc. (RMD) presents one of the most complex investment paradoxes in the current medical technology landscape. On the surface, the company appears to be a quintessential “compounder”—a business with a dominant market share (exceeding 80% in key regions), a wide competitive moat forged by a digital […]

Episode metadata supplied by the publisher feed · Published Feb 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

ResMed Inc. (RMD): An Asymmetric Risk Analysis of the Sleep-Disordered Breathing Monopoly

0:00 41:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gemini Brief - Investment Deep Dives?

This episode is 41 minutes long.

When was this The Gemini Brief - Investment Deep Dives episode published?

This episode was published on February 1, 2026.

Can I download this The Gemini Brief - Investment Deep Dives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!